Live feed16:54:38·491dINSIDERFilingvia QuantisnowChief Scientific Officer Mahaney Paige was granted 28,200 shares, increasing direct ownership by 37% to 105,000 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CCCC· C4 Therapeutics Inc.Health CareOriginal source
